All the news Showing 10 of 36 articles from: Triple therapyGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources NICE consults on draft guidance on the drug simeprevir (Olysio) for treating hepatitis C NICE / 25 September 2014 Paritaprevir (ABT-450)/ombitasvir/dasabuvir- List Of Upcoming and Recruiting Clinical Trials hepatitiscnewdrugs.blogspot.co.uk / 21 August 2014 CHMP summary of opinion: simeprevir (Olysio) European Medicines Agency / 24 March 2014 Simeprevir receives positive CHMP opinion for the treatment of adults with chronic hepatitis C in the European Union Medivir press release / 21 March 2014 J&J-Medivir Drug for Hepatitis C Recommended by EU Regulator Bloomberg Businessweek / 21 March 2014 New Phase III Data from Once-Daily Simeprevir Presented at the Conference of the Asian Pacific Association for the Study of the Liver (APASL) Medivir press release / 17 March 2014 Treating HCV -- Is the Price Right? Med Page Today / 19 February 2014 Deferral of treatment in HCV patients: Risks and benefits Hepatitis B & C Public Policy Association / 17 February 2014 Experimental treatment cures Ottawa wrestler of hepatitis C CBC / 14 January 2014 Phase III data show Boehringer Ingelheim’s faldaprevir is effective even in patients with common drug-resistant viral variant Boehringer-Ingelheim press release / 16 December 2013 ← First123...4Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive